Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wagner S Brum

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Nature Aging|August 31, 2023
A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain casesWagner S Brum, Nicholas C Cullen, Shorena Janelidze, et al.
Ebiomedicine|February 14, 2022
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's diseaseNicholas J Ashton, Andréa L Benedet, Tharick A Pascoal, et al.
Nature Communications|March 15, 2024
A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settingsWagner S Brum, Nicholas C Cullen, Joseph Therriault, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumIlaria Pola, Nicholas J Ashton, Marco Antônio De Bastiani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 6, 2024
Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented Alzheimer's risk-enhanced sampleLianlian Du, Rebecca E Langhough, Rachael E Wilson, et al.
Brain, Behavior, and Immunity|March 6, 2023
Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologiesMarco Antônio De Bastiani, Bruna Bellaver, Wagner S Brum, et al.
Alzheimer'S Research & Therapy|March 10, 2023
Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohortsJuan Lantero-Rodriguez, Agathe Vrillon, Aida Fernández-Lebrero, et al.
Alzheimer'S Research & Therapy|February 19, 2025
The impact of kidney function on Alzheimer's disease blood biomarkers: implications for predicting amyloid-β positivityBurak Arslan, Wagner S Brum, Ilaria Pola, et al.
Acta Neuropathologica|January 6, 2024
CSF p-tau205: a biomarker of tau pathology in Alzheimer's diseaseJuan Lantero-Rodriguez, Laia Montoliu-Gaya, Andrea L Benedet, et al.
Acta Neuropathologica|April 21, 2025
Correction: CSF p-tau205: a biomarker of tau pathology in Alzheimer's diseaseJuan Lantero-Rodriguez, Laia Montoliu-Gaya, Andrea L Benedet, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Nature Aging|August 31, 2023
A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain casesWagner S Brum, Nicholas C Cullen, Shorena Janelidze, et al.
Ebiomedicine|February 14, 2022
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's diseaseNicholas J Ashton, Andréa L Benedet, Tharick A Pascoal, et al.
Nature Communications|March 15, 2024
A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settingsWagner S Brum, Nicholas C Cullen, Joseph Therriault, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumIlaria Pola, Nicholas J Ashton, Marco Antônio De Bastiani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 6, 2024
Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented Alzheimer's risk-enhanced sampleLianlian Du, Rebecca E Langhough, Rachael E Wilson, et al.
Brain, Behavior, and Immunity|March 6, 2023
Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologiesMarco Antônio De Bastiani, Bruna Bellaver, Wagner S Brum, et al.
Alzheimer'S Research & Therapy|March 10, 2023
Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohortsJuan Lantero-Rodriguez, Agathe Vrillon, Aida Fernández-Lebrero, et al.
Alzheimer'S Research & Therapy|February 19, 2025
The impact of kidney function on Alzheimer's disease blood biomarkers: implications for predicting amyloid-β positivityBurak Arslan, Wagner S Brum, Ilaria Pola, et al.
Acta Neuropathologica|January 6, 2024
CSF p-tau205: a biomarker of tau pathology in Alzheimer's diseaseJuan Lantero-Rodriguez, Laia Montoliu-Gaya, Andrea L Benedet, et al.
Acta Neuropathologica|April 21, 2025
Correction: CSF p-tau205: a biomarker of tau pathology in Alzheimer's diseaseJuan Lantero-Rodriguez, Laia Montoliu-Gaya, Andrea L Benedet, et al.
Pageof 6